Form 4 for AZZ AZZ INC
Accepted 2021-07-26 00:00:00 ET · period of report 2021-07-22 · accession 0000008947-21-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-26 | 2021-07-22 | AZZ | Bacius Chris M. | VP, Corp. Development | M - OptEx | $46.34 | +2,724 | 19.7K | +16% | +$126.2K |
| D | 2021-07-26 | 2021-07-22 | AZZ | Bacius Chris M. | VP, Corp. Development | D - Sale to Iss | $52.09 | -2,424 | 17.3K | -12% | -$126.3K |
| D | 2021-07-26 | 2021-07-22 | AZZ | Bacius Chris M. | VP, Corp. Development | F - Tax | $52.09 | -73 | 17.2K | -0.4% | -$3,803 |
| D | 2021-07-26 | 2021-07-22 | AZZ | Bacius Chris M. | VP, Corp. Development | M - OptEx | $0.00 | -2,724 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-07-22 | M | A | 2,724 | $46.34 | 19,706 | D | — | — | |
| 2 | Common | COMMON STOCK | 2021-07-22 | D | D | 2,424 | $52.09 | 17,282 | D | — | — | (F1) Shares forfeited for the conversion of stock appreciation rights ("SARs"), which were settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price ($46.34) over the exercise prices ($52.09). |
| 3 | Common | COMMON STOCK | 2021-07-22 | F | D | 73 | $52.09 | 17,209 | D | — | — | (F2) The reporting person forfeited 73 shares of common stock to satisfy tax withholding obligations on the exercised SARs. |
| 4 | Derivative | STOCK APPRECIATION RIGHTS | 2021-07-22 | M | D | 2,724 | $0.00 | 0 | D | — · — to — | 2,724 COMMON STOCK | (F3) The conversion of SARs are settled in shares of AZZ common stock in an amount equal to the excess value of the grant date price of ($46.34) over the exercise price of ($52.09) on the exercise date. (F4) On September 1, 2014, the reporting person was granted SARs, which vested ratably over a three-year period beginning on March 1, 2015. (F5) The SARs granted on September 1, 2014 have an expiration date of September 1, 2021. |